chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cidp; Initial information received on 13-Nov-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-healthcare professional.  This case involves a patient of unknown age and demographics who experienced CIDP after receiving vaccine Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  In Nov-2012, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Flu (Influenza).  On an unknown date, the patient developed a serious event of CIDP (chronic inflammatory demyelinating polyradiculoneuropathy) (unknown latency) following the administration of influenza vaccine. This event was assessed as medically significant.  No lab data was reported.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (CIDP).  At time of reporting, the outcome was Unknown for the event CIDP.; Sender's Comments: Sanofi company comment dated 19-Nov-2022: This case involves a patient of unknown age and demographics who experienced CIDP after receiving vaccine Influenza vaccine. The time to onset was compatible with the role of vaccine. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Wide spread rash, itching, patient given antihistamines, felt rash was stable at 36 hours after onset of symptoms, main concern at visit today wash itching.
Information has been received from a medical assistant through the Merck pregnancy registry concerning an approximately 15 year old female patient with no pertinent medical history or drug reactions/allergies, who in November 2006, was vaccinated intramuscularly with the first dose of Gardasil (0.5 ml). There was no concomitant medication. It was reported that the patient did not receive her second vaccination due to pregnancy. The patient subsequently had a miscarriage. The date of miscarriage was not known. Upon internal review, the miscarriage was felt to be an other important medical event. Additional information has been requested.
No issue at the time of vaccination or after.. Was receiving an unrelated screening 03/14/2023 and the doctor told me she thought I had a-fib and gave me a referral to a cardiologist.
arm pain all the way down to fingers unable to lift arm past head dizzy weak headache nausea chills no fever exhausted no appetite arm pain is 60% better today no redness at injection site mild swelling at injection site mentally foggy weak vision
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Aug2023 at 16:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 69 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19, the patient received paxlovid from 29Sep2023 to 03Oct2023.   The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
pt recv vax JAN99 & w/in 24hr pt devel low grade fever, gastrointestinal sx & a rash on face & back;pt recovered w/in 10 days;
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 04-NOV-2012 10:24, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Trouble breathing; Acute migraine; Hives; Muscular pain; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration, in Arm Right on 26Feb2021 13:15 (at the age of 41 years old), as single for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. The patient did not receive other vaccine within four weeks of COVID vaccine and she did not take other medications within two weeks of vaccination. The patient did not have COVID prior to vaccination. The patient concomitant medications were not reported. On 28Feb2021 15:00, the patient experienced trouble breathing, acute migraine, hives, and muscular pain. These adverse events resulted in emergency room/department or urgent care visit. The patient received treatment with benadryl and pain medicine. The patient did not test for COVID post vaccination. The outcome of all the events were resolved, on an unspecified date in 2021.
Information has been received from a Licensed Vocational Nurse referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On unknown dates the patients were vaccinated with improperly stored doses ROTATEQ, orally (strength, dose, dose number, lot # and application site were not reported). Concomitantt therapy was not reported. No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
On Thursday afternoon, patient experienced a swollen and inflamed right knee. On Friday morning, he developed a swollen bottom lip. By Friday afternoon, he had a swollen and inflamed left knee. We took him to urgent care and the ER and all other theories  for its cause came back negative. On Saturday, he had swollen and inflamed hands right around his thumb joints  and a swollen upper lip. On Sunday, he developed swelling around his eyes and a rash. All swelling lasted for about 12 hours before it hopped to another part of the body. The swelling was debilitating for that period of time (swollen knees made it impossible to walk, swollen hands made it impossible to grasp things). Patient is now doing better but he was perfectly healthy before taking the vaccine.
This spontaneous report as received from a pharmacist via sales representative refers to an unknown age and gender patient. Medical history was not reported. On an unknown date the patient was vaccinated with ZOSTAVAX lot number, expiration date, route and dosage were unknown. Concomitant therapy was unknown. The reporter informed that on an unknown date the patient had come down with shingle 3 or 4 days post vaccination with ZOSTAVAX. The patient sought unspecified medical attention. The patient's outcome with the event was unknown. Additional information has been requested.
Felt very tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt very tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced FATIGUE (Felt very tired). At the time of the report, FATIGUE (Felt very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
This consumer (Patient's mother) reported that a female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date single dose for COVID-19 immunization.  Medical history included hair color. Historical vaccine included 1st dose of BNT162B2 for COVID-19 immunization. The patient had her second dose 3 weeks ago, her mother did her hair color today and she had an allergic reaction to it. There was not anything different her mother done the same color for 3 years. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fainted 15 minutes after receiving vaccination dose. I am not afraid of needles and was not nervous at time of vaccination. After lying down for 10 minutes and drinking water, I felt better, though I continued to feel light headed for the rest of the day. Following that initial reaction, I had a bit of light headedness for a few days but it eventually resolved. Then, 3 weeks after vaccination, I started having mild/moderate but noticeable strange symptoms: numbness in my feet, tingling in my hands, weakness in my arms, sharp stabbing pain in my legs (reminiscent of mild electric shock or cramping) that would last a few minutes at a time. I have never experienced these symptoms before and I know they are connected to the vaccine. I am a healthy 33 year old with no prior issues. These symptoms are uncomfortable but fortunately they are not constant. They come up a few times a day and especially at night as I am going to sleep.
No adverse event - just an expired dose administer  Pneumovax 23 expires 10/15/2022
Information obtained from clients wife. patient received his first dose of Moderna 2/24/21 lot 024M20A  with no reported issues except for a sore arm. patient received his second dose of Moderna on 3/24/21; Lot# 006B21A. No immediate effects from the vaccine. On day 2 post vaccination, patient became to have chills, per wife; did not check temperature and denied any symptoms such as flu-like symptoms. Day 3 post vaccination; patient began to have weakness in the legs. March 31st; patient was unable to stand and the rescue squad was called. patient was taken to the Hospital; where he was evaluated and released home. Pt collapsed at 1am 4/1/2021 and died 4/1/21.
pt recvd vax & arm was red , swollen & itching; pt had some chills & fever 3-4 days after shot; pt arm was sore;
Vaccine was administered to patient more than 6 hours after dilution (given 13 hours, 14 minutes after this).   Vaccine was drawn up from vial immediately before administration.
Heart racing, chest feels tight,  chest pressure. Upper right side, No radiation of pain in jaw , back or other extremity. She had an ekg that sis not have any ST elevation. No real relief at this time. She feels her heart pounding at times. We discussed adding a beta blocker. She states that she will have the chest discomfort, palpitations together. This is unlike her normal anxiety symptoms. She has not been sleeping well.
This case was reported by a consumer via call center representative and described the occurrence of ganglion in a patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included complex regional pain syndrome (on upper extremities). On 21st March 2019, the patient received the 1st dose of SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced ganglion, pain localized and inflammation localized. On an unknown date, the outcome of the ganglion, pain localized and inflammation localized were unknown. It was unknown if the reporter considered the ganglion, pain localized and inflammation localized to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was reported. The case was reported by the patient for themselves. The patient stated that they received the shingles vaccine 2 day ago before reporting on their thigh (unspecified) and the ganglion on the extremity the vaccine was put on was inflamed and painful. The patient wanted to know if it was normal. At the time of this report, it was unknown if the suspect vaccine was SHINGRIX or not.
Within 7-10 days of recieving the vaccine, he broke out in a red rash and spiked a fever of approx. 101.  I kept it down to 100.5 with Ibuprofen and Tylenol as instructed per the physicians office by phone.  Within a week, the rash and fever were gone and he began having violent tantrums (beating his head on the floor).  His speech and eye contact went away over the next few weeks.  Diagnosis, Autism.  Over two years after he recieved this vaccine, his measles IgG was still elevated at 789, indicating a chronic measles infection.  Chronic diarrhea and self injurious behavior have plagued him since the vaccination. Medical Records received on 1/26/2005 states autism.
This spontaneous report was received from a physician refers to a 18 year old female patient. The patient has no pertinent medical history or drug reactions/allergies. On 30-AUG-2012, the patient was vaccinated with GARDASIL, lot number reported as (0420AE), expiration date 01-DEC-2014. Concomitant medications included: ADACEL which was administered on 30-AUG-2012 to a separate site. On an unknown date in September 2012, the patient was found to be pregnant with nausea. The last menstrual period (LMP) was on 06-AUG-2012 and an estimated date of delivery (EDD) of 13-MAY-13. The patient was exposed to GARDASIL during first trimester. On 30-AUG-2012, pregnancy test was performed (prior to GARDASIL vaccination) which was negative. On 05-SEP-2012, pregnancy test was performed which showed positive result. The reporter was not sure when the patient started to experience nausea. Treatment rendered for the events included over the counter vitamin B6 and an unspecified prenatal vitamin. The outcome of the events were reported as not recovered at the time of this report. The patient sought medical attention (office contact). Additional information has been requested.
Still having cold feet which are not getting warm/ feet become very cold; Soreness in the arm at the injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (Still having cold feet which are not getting warm/ feet become very cold), VACCINATION SITE PAIN (Soreness in the arm at the injection site) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Seafood allergy (Allergic to shrimp).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL COLDNESS (Still having cold feet which are not getting warm/ feet become very cold). In April 2021, the patient experienced VACCINATION SITE PAIN (Soreness in the arm at the injection site) and HEADACHE (Headache). At the time of the report, PERIPHERAL COLDNESS (Still having cold feet which are not getting warm/ feet become very cold) had not resolved and VACCINATION SITE PAIN (Soreness in the arm at the injection site) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Ultrasound scan: normal (normal) ultrasound of blood pressure for ankle and toe were normal.         No concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-073774 (E2B Linked Report). This case was linked to MOD-2021-073774 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: follow-up document received on 15 Jul 2021; included reporter detail, laboratory data, date of the event (Cold feet) and outcome of event. On 15-Jul-2021: followup document received on 15 Jul 2021 contain NNI.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073774:Dose 1
Myocarditis  Heart failure  Cardiac cath- takotsubo  Lopressor and lisinopril.  Hospitalized x2 in one week  12/1/2021 to 12/8/2021
Woke up on Wednesday, 2/24, approx. 12:00am to my entire left arm numb. Woke up and numbness changed to tingling m. Tingling began to move up arm into neck and upper back then mid back. Then into left side of face and teeth. (No paralysis or Bells palsy - went away in 45 min) By Thursday morning tingling traveled to right right rib cage and feet, settling into hands and feet. Blurry, hard to focus vision. Went to ER on Thursday, 2/25. Not admitted. Discharged with recommendation to do MS workup. Tingling in hands turned to weakness in both hands on Friday. Left wrist and elbow joint pain. Tingling and numbness have persisted in hands and feet. Burning sensation on skin.
Patient received a second flu shot again on 10/9/2021. I spoke to patient, she did not experience any adverse effects.
No adverse symptoms reported; received an improperly stored dose of VARIVAX; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical histories and concomitant medications were not provided. On 20-JUL-2020, the patients were vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot number S036636, expiration date 14-NOV-2021 (dose and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 15 to 46 (34.5) degrees Fahrenheit for 1 hour 22 minutes and 30 seconds. There was previous temperature excursion of 6 to 14 (9) degrees Fahrenheit for 52 minutes. Digital data logger was involved. The were no information how the sterile diluent used to reconstitute the varicella virus vaccine live (oka/merck) (VARIVAX) was stored. No additional adverse effect was reported.
Bad headache for 7 days; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 61 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 02Apr2021 10:00 (Lot number: Ap7533) at the age of 61 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "known allergies:sulfur" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "Ulcerative colitis" (unspecified if ongoing). Concomitant medication(s) included: AZELASTINE; APRISO; LIBRAX [CHLORDIAZEPOXIDE;CLIDINIUM BROMIDE]; PANTOPRAZOL [PANTOPRAZOLE SODIUM SESQUIHYDRATE]; VORTIOXETINE. Past drug history included: Compazine, reaction(s): "Drug allergy"; Tigan, reaction(s): "Drug allergy"; Morphine, reaction(s): "Drug allergy"; Promethazine, reaction(s): "Drug allergy". The following information was reported: HEADACHE (non-serious) with onset 02Apr2021 10:15, outcome "recovered" (Apr2021), described as "Bad headache for 7 days". Therapeutic measures were taken as a result of headache. Additional information: Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. Patient did not receive any vaccines within four weeks prior to the vaccination. Bad headache was treated with sumatriptan and EMGALITY from 04Apr2021 to an unknown stop date.  No follow-up attempts are possible. No further information is expected.
On Friday June 4th I visited a friend who informed me that she had just received the Pfizer vaccine. We hugged and spent several hours together during which I ate food that she prepared which included a raw carrot salad.  On Sunday June 6th at 1 pm, I noticed I felt very tired, which is unusual for me. At 4:15 I suddenly noticed a large bump inside my mouth on my right cheek near where my teeth come together.  I went to look in the mirror and saw a large deep purplish red blood blister that was the size and shape of half a marble. I popped it, the blood came out, but otherwise it did not seem to bleed. I put H202 on it, there was no pain. By about June 8th it had almost completely healed leaving only a slightly pinkish circle where it had been. Other than the fact that this was so much larger and so much more spherical than any blood blister I had ever had before (and it's been years since I did -- and they were ALWAYS the result of injuring my cheek -- which had not happened this time.) I didn't think much of it.  Then on Wednesday June 9th 4:08 pm, I suddenly noticed another large bump in the same general area.  I went to look in the mirror and saw another blood blister about the same size and shape of the first one -- but this one was slightly farther back and a tad lower in my mouth compared to the now slightly darker spot where the first one had been.  I popped this one and put H202 on it -- but a lot more blood came out of it -- at least a teaspoon and it just kept bleeding and bleeding. Then it bled several more times again over the next few days as well. It was also very painful. At first there was an inch long piece of loose skin hanging in my mouth -- but after two days, it had disappeared, but the pain continued on. There was a huge raw ulcer more than half an inch long and not quite as tall -- raw and red that would bleed from the slightest touch -- but it was completely flat, I could not feel any lump in my cheek from the inside nor the out. But unlike the first blister, this one just didn't seem to heal, so I started trying different things like gargling with salt water, and applying turmeric powder --- nothing seemed to help at all.  It was the amount of bleeding that caused me to connect this with my having been exposed to my just vaccinated friend -- as I had been hearing from so many others that they experienced prolific bleeding (from nose or vagina) after close contact with a just vaccinated person. And then the fact that this was so bizarre and not like any other event I have ever had. And also the fact that it just didn't seem to heal as fast injuries inside my mouth always have -- and did with the first blister.  It is now nearly a week since I first got the second blister. The circumference has shrunk to the size of a pea, but the middle is still as raw as ever and I am in constant pain, which is pretty alarming. I noticed on the trial protocol that it alludes to the fact that exposures to the vaccine can happen to people who did not get the injection but were exposed to the skin or breath of someone who did. That is what prompted me to file this report
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 4 years old child patient and unknown gender. On 03-SEP-2014 the patient was vaccinated with PROQUAD (Merck) (lot # K006771, expiration date 07-NOV-2015) (dose, route not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. The reporter also stated that as of 29-AUG-2014 they had 18 doses left of this lot number. This is one of several reports received from the same source. Additional information has been requested.